Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00093236 · ClinicalTrials.gov registry record · NA

Impact of Gum Infection on Heart Disease

A NA study of Cardiovascular Disease and Periodontal Disease, sponsored by Boston University.

Completed
Registry status
NA
Development phase
174
Enrollment target
1
Study location

NCT00093236: Completed NA study of Cardiovascular Disease and Periodontal Disease, sponsored by Boston University.

NCT00093236 is a NA study of Cardiovascular Disease and Periodontal Disease that has completed, run by Boston University. The registered enrollment target is 174 participants, below the 2,696-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00093236, a NA study of Cardiovascular Disease and Periodontal Disease, has completed, sponsored by Boston University.

COMPLETED
Registry status
NA
Development phase
174 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the effect of gum infection on parameters of cardio-vascular disease.

Primary Outcome

Three weeks after initiation of the study, they will return and be re-evaluated for the need for periodontal surgery. If indicated, they will then receive definitive periodontal surgery over the next 4 weeks. At the 12-week time point, periodontal surgery will be reevaluated and further therapy provided as needed and make repeated visits as needed to achieve periodontal health. During this period, the Usual Hygiene Group will return for oral hygiene visits at the 3 and 12-week time points. After

Interventions

  • PROCEDURE Early Periodontal Treatment
  • PROCEDURE Usual Dental Hygiene

Study Locations (1)

Massachusetts

  • Boston University Medical Campus - Boston

Trial Details

FieldValue
Enrollment Target 174 participants
Start Date 2004-09
Est. Completion 2012-12-08
Phase NA
Boston University

185 total trials

What the finished NCT00093236 record still lists

NCT00093236 is an interventional study that assigns participants to a tested intervention. The registered 174 participants enrollment target is mid-sized for trials with a published cap, below the 2,696-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (94% lower).

The record links to 2 conditions, with Cardiovascular Disease appearing as the primary indexed condition, and to 2 interventions - of which Early Periodontal Treatment is the first listed.

NCT00093236 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00093236 about?

NCT00093236 is a clinical study titled "Impact of Gum Infection on Heart Disease". The purpose of this study is to determine the effect of gum infection on parameters of cardio-vascular disease.

What is the current status of trial NCT00093236?

This trial is currently completed. It is a NA study. The enrollment target is 174 participants. The study started on 2004-09. Estimated completion is 2012-12-08.

What conditions does trial NCT00093236 study?

This clinical trial studies the following conditions: Cardiovascular Disease, Periodontal Disease.

What interventions are being tested in trial NCT00093236?

The interventions under investigation include: Early Periodontal Treatment (PROCEDURE), Usual Dental Hygiene (PROCEDURE).

Who is sponsoring clinical trial NCT00093236?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00093236 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00093236's enrollment target sits among peer trials

174 55th of 137 higher than 83 of 137 other Cardiovascular Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01000259 · 174 participants

    Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

  • NCT04729114 · 174 participants · Phase 1

    A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

  • NCT04884035 · 174 participants · Phase 1

    Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

  • NCT05075980 · 174 participants · Phase 2

    Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00093236, the US trial registry maintained by the National Library of Medicine. NCT00093236 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.